Delivery Order SPE2DB20D2104-SPE2DB25FMNRJ

Award Date 4/16/25
Potential Completion Date 4/17/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML. The $2,724.68 firm fixed-price contract has a completion date of March 19, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a $1,697.81 Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The contract provides for the delivery of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product, to support federal government medical requirements. The contract has a period of performance through May 8, 2024 and was not set aside for any specific business category. AmerisourceBergen Drug Corp is a major pharmaceutical...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $32,599.85 contract is for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a specialty pharmaceutical product. The delivery order has a performance period through March 14, 2024. Amerisourcebergen Drug Corp serves as a prime contractor for DLA, providing a wide...
This is a $16,095.56 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product. The contract has a period of performance through December 20, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded under an Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,213.11 firm fixed-price contract is to provide the drug YUPELRI 175 MCG/3 ML SOLUTION UD 3ML to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of March 19, 2024. AmerisourceBergen holds a $999,999,999 IDC with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the pharmaceutical product YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, with a ceiling value of $1,296.92 and a completion date of November 14, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,194.54 firm-fixed-price delivery order is for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a medical drug product. The contract has an ultimate completion date of April 20, 2023. AmerisourceBergen is the prime contractor, and there is no indication of any...
This federal contract award, valued at $2,937.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of the pharmaceutical product YUPELRI 175 MCG/3 ML SOLUTION UD 3ML. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,515.98 firm fixed-price contract is for the delivery of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has an ultimate completion date of April 15, 2025. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for $41,014.70 on a firm fixed-price basis, with a period of performance running through February 2025. The contract provides for the delivery of various pharmaceutical products and medical supplies to support military healthcare programs. AmerisourceBergen holds a larger...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMNRJ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,916.98, is for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order is not designated as a set-aside contract.

Generated 7/16/25, 12:22 PM